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Wound complications are an important cause of postoperative morbidity
among patients with gynaecologic malignancies. We evaluated whether the
placement of closed-incisional negative pressure therapy (ciNPT) at the time of
laparotomy for gynaecologic cancer surgery reduced wound complication
rates. A retrospective cohort study with primary wound closure performed by
a gynaecologic oncologist was carried out. We evaluated two cohorts of
patients who underwent surgery in 2017 with standard closure and patients
who underwent surgery in 2019 with the placement of prophylactic ciNPT.
Postoperative outcomes were examined. A total of 143 patients were included,
85 (59.4%) vs 58 (40.6%) with standard closure and ciNPT, respectively. The
total complication rate in our sample was 38.71%. The rate of surgical compli-
cations in patients treated with ciNPT was 6.9% compared with 31.8%
(P = .000) in patients treated with standard closure. In the analysis of compli-
cations, a significant reduction in infections (17.1%), seromas (15.4%), and
wound dehiscence (17.1%) were observed when ciNPT was applied. The
median hospital stay was 8 vs 6 days in the standard closure vs ciNPT groups
(P = .048). The use of the prophylactic ciNPT following a laparotomy may
decrease wound complications and hospital stays in oncological patients.
ciNPT could be considered as part of clinical practice in patients at high risk of
wound complications, such as patients with gynaecological malignancies.
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Key Messages
• surgical wound complications are currently a challenge for oncology gyn-
aecologists with an impact on the morbidity and mortality of our patients
• a total of 143 patients underwent xipho-pubic laparotomy, 85 with standard
closure and 58 with negative pressure incisional therapy were evaluated
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• the application of negative pressure incisional therapy is presented as a pro-
phylactic option that could reduce wound complications
1 | INTRODUCTION
Despite advances in the practice of minimally invasive
surgery and the widespread adoption of these techniques,
a significant proportion of the patients diagnosed with a
primary gynaecologic malignancy will require surgical
management with laparotomy in the treatment of
disease.1-3
A balance between optimal surgical treatment and
reduction of postoperative morbidity and mortality for these
patients continue to challenge gynaecologic oncologists.
Wound complications could be as high as 40% to 60%4
and lead to extended hospital stays and decreased quality of
life.5-7
This category of adverse events related to surgery
includes wound separation, hematoma, seroma, and
superficial surgical site infection (SSI).
Most worrisome in the gynaecologic oncology patient
is the adverse impact of wound complications at the pri-
mary surgical site on overall survival, as evidenced in
patients with ovarian cancer, with a hazard ratio 1.69
(1.12-2.57) in patients with a superficial SSI.2,8
Increased operative time, surgical complexity, esti-
mated blood loss, and medical comorbidities, such as
obesity, have been identified as independent factors
predisposing patients to wound complications.3,8-10
The prophylactic use of closed-incisional negative
pressure therapy (ciNPT) over closed incisions reduced
the incidence of SSIs and wound complications in surgi-
cal patients in other surgical disciplines.5-7,11-13 However,
there is scant literature regarding this therapy among
gynaecologic patients.
The purpose of the current study was to determine
whether prophylactic ciNPT decreases the wound
complications in patients with gynaecologic malig-




Two consecutive cohorts of patients who underwent
abdominal laparotomy with a diagnosis of gynaecological
neoplasia performed at the Bellvitge University Hospital,
Barcelona, were retrospectively evaluated.
A cohort between January 2017 and December 2017
when ciNPT was not used, and a cohort who underwent
surgery between January 2019 and December 2019 when
a ciNPT protocol was fully standardised in our
department.
The primary objective of this study was to compare
the rate of postoperative wound complications between
the two groups of patients.
Prophylactic measures for SSI were standardised
according to hospital protocol in accordance with the US
Centers for Disease Control and Prevention (CDC)
guidelines.
2.2 | Inclusion and exclusion criteria
Patients were required to meet all the following eligibility
criteria:
• Age older than 18 years;
• Diagnosis of gynaecologic malignancy by biopsy;
• Cytoreductive surgery that required a midline laparotomy;
• Written informed consent for surgery and data collection.
Patients who had a benign pathology, no consent for
data collection or who underwent minimally invasive
surgery, were not included in the analysis.
2.3 | Protocol
All patients (regardless of the cohort evaluated) received
the same preoperative and postoperative care. They were
shaven using surgical clippers when required, and the
skin was prepared with povidone iodine solution.
Cefuroxime (1.5 g) was administrated 60 minutes
before the incision in every surgery, and it was re-
administered according to the length of surgery and
blood loss. There was no administration of post-surgical
antibiotic therapy.
In those patients who did not receive ciNPT, the
placement of the sterile gas dressing was maintained for
24 to 48 hours.
• ciNPT device:
The negative pressure therapy device was applied at
the time of closing the wound incision.
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Negative pressure dressings were applied to clean, dry
incision sites after closure of intradermal sutures with
the Quill bearded suture.
The device consisted of a dressing composed of
KCI GranuFoam with bacteriostatic and bactericidal
capacities and a vacuum-assisted closure system
(Prevena Incision Management System, KCI, San
Antonio, Texas) was applied with continuous negative
pressure at 125 mmHg and a reservoir of 45 mL
capacity.
If an ostomy was present, the incisional negative pres-
sure system was placed after the ostomy devices.
The ciNPT dressings were continued between 2 and
9 days postoperatively. The wound was evaluated after
removal of the device if there was no evidence of bleeding
in the reservoir.
• Follow-up:
Surgical wound complications, such as infections, ser-
omas, haematomas, or superficial dehiscence, were
reported until 30 days after surgery.
The superficial surgical wound infection was classified
when the infection involved the skin and subcutane-
ous tissue and occurred within 30 days of injury
according to the definition by the CDC.14,15
The clinical team recorded signs or symptoms of
wound-related infections in the medical record per
routine clinical practice.
A seroma was recorded whenever fluid leaked from
the wound. A haematoma was recorded when clots
leaked through the wound. Dehiscence was recorded
when the separation of skin and dermal surfaces was
observed, without affecting the fascia.
Clinical variables were collected and included age,
ECOG status (ECOG scale is a practical way to mea-
sure the quality of life of a patient exclusively with can-
cer or oncology), type of cancer and FIGO stage (FIGO
stage [International Federation of Gynaecology and
Obstetrics] is the staging system for gynaecological
cancers based on their extension and prognosis), body
mass index (BMI, kg/m2), tobacco use, diabetes
mellitus, previous abdominal surgeries, and the use of
abdominal mesh in the current surgery because
of increased seroma in these cases.
• Data analysis:
Categorical variables were analysed using chi-square
test or Fisher's exact test, whereas continuous variables
were analysed using Student's t test.
The ANOVA statistical test was used to compare the
means of both samples to show homogeneity.
These analyses were carried out using IBM SPSS Statis-
tics for Windows, version 25.0, and a 5% level of
statistical significance was considered throughout the
study.
3 | RESULTS
A total of 143 patients underwent middle laparotomy for
gynaecologic oncological disease in the period reviewed.
Of these patients, 85 patients received a conventional
dressing and 58 patients received ciNPT.
The characteristics of the patients are identified in
Table 1. The groups were similar in ages, prevalence of
diabetes, numbers of previous abdominal surgeries,
and rates of use of abdominal mesh in the wall closure.
There were no significant differences in BMI in both
groups.
The type of gynaecologic cancer and FIGO stages did
not show significant differences in the global statistical
analysis (P = .239 and .198, respectively) (Table 2).
Although without significance, an increase in the propor-
tion of ovarian cancer in the standard closure group com-
pared with that in the ciNPT group, 71.8% (61) vs 56.9%
(33), was observed (Table 2). This difference is not con-
sidered relevant, because all patients present the same
type of surgical approach; laparotomy middle xipho-
pubic.
In the same sense, the patients with diagnosis of a
metastatic tumour, recurrence, or absence of tumour in
the surgical intervention did not present with differences
in the two subgroups evaluated.
Overall, 51.8% (44) vs 43.1% (25) of the patients were
stage III among the two groups, respectively, although
again without a significant difference in the global statis-
tical study (P = .198).
The incidence of wound complications in our study
population was 38.71% in total, of which 31.8% occurred
in the standard closure group, and only 6.9% in the ciNPT
group. (P = .000).
The wound complications experienced by patients
included in this study are described in Table 3. We
observed a lower incidence of superficial SSIs, seromas,
and wound dehiscence in the ciNPT group with signifi-
cant differences when compared with those in the stan-
dard closure group.
The length of hospital stay was reduced in patients
who received ciNPT compared with patients who
received standard closure (6.18 days vs 8.86 days, respec-
tively; P < .05).
In the subgroup analysis of patients with a BMI
≥30 kg/m2 (obesity), we observed lower rates of seromas,
infections, wound dehiscence, and haematomas with sig-
nificant differences in the ciNPT group than those in the
standard closure group (Table 4).
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4 | DISCUSSION
SSI remains stable despite efforts to standardise perioper-
ative care, which contributes to an increase in surgical
morbidity and medical costs.16,17
The reported historical rates of SSI are 5% to 15% for
clean-contaminated (class II), 15% to 30% for contami-
nated (class III), and >30% for dirty (class IV).18,19
Furthermore, the rates of surgical complications in
patients with gynaecologic cancers are between 40% and
TABLE 1 Patient
demographic data
Standard closure (85) ciNPT (58) P
Age 61.51 63.28 .366
BMI, kg/m2 27.59 28.59 .323
Diabetes (n) 22.4% (19) 20.7% (12) .813
Abdominal mesha (n) 25.9% (22) 22.4% (13) .636
Previous abdominal surgery (n) 58.8% (50) 53.4% (31) .529
Note: Data are presented as mean and % and were analysed using ANOVA statistical test, which was used to
compare the means of both samples to show homogeneity.
Abbreviation: ciNPT, closed-incisional negative pressure therapy.
aPatients who received abdominal mesh at the time of surgery.
TABLE 2 Cancer dataStandard closure (85) ciNPT (58) P
ECOG ≤1 (N) 100% (85) 100% (58) 1
NACT (n) 25.9% (22) 22.4% (13) .636
Pathology (n) .239
Ovarian cancer 71.8% (61) 56.9% (33)
Cervical cancer 1.2% (1) 0%
Endometrial cancer 23.5% (20) 34.5% (20)
Vulvar cancer 1.2% (1) 0%
No tumour 2.4% (2) 0%
Metastasis 2.4% (2) 17.2% (5)
Recurrence 5.9% (5) 17.2% (10)
FIGO stage (n) .198
I 15.3% (13) 19% (11)
II 11.8% (10) 6.9% (4)
III 51.8% (44) 43.1% (25)
IV 10.6% (9) 5.2% (3)
Note: Data are presented as mean and % and were analysed as categorical variables using chi-square test or
Fisher's exact test, whereas continuous variables were analysed using Student's t test.
Abbreviation: ciNPT, closed-incisional negative pressure therapy.
TABLE 3 Results of postoperative
outcomes
Standard closure (85) ciNPT (58) P
Postoperative stay (days, mean) 8.86 6.16 .036
Complications (n) 31.8% (27) 6.9% (4) .000
Superficial infection (SSI) 18.8% (16) 1.7% (1) .000
Seroma 18.8% (16) 3.4% (2) .002
Wound dehiscence 18.8% (16) 1.7% (1) .000
Haematoma 9.4% (8) 1.7% (1) .064
Note: Data are presented as mean and % and were analysed as categorical variables using chi-square test or
Fisher's exact test, whereas continuous variables were analysed using Student's t test.
Abbreviation: ciNPT, closed-incisional negative pressure therapy.
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60% because of the incidence of associated comorbidities,
particularly obesity.8,9,20,21
According to our results, the complications of surgical
wounds in both cohorts were lower than those published
in similar populations, being 18.4% in patients with stan-
dard closure, decreasing to 2.7% in patients with ciNPT.
The use of ciNPT has shown inconclusive results in the
literature.9,12,22 Consequently, its implementation in the pre-
vention of surgical wound complications remains in debate.
Our results show a significant reduction in superficial
SSI (18.8% vs 1.7%), seromas (18.8% vs 3.4%), and wound
dehiscence (18.1% vs 1.7%), which represents a reduction
of 91% for superficial SSI and wound dehiscence, and
82% for seroma when ciNPT is applied after laparotomy
for gynaecologic malignancies. Furthermore, this study
shows that the differences obtained in surgical complica-
tions after ciNPT were maintained in the analysis of
obese patients (BMI ≥30 kg/m2).
The reduction in surgical site complications is
because ciNPT decreases the fluid accumulation in a
sealed manner, improving perfusion and oxygenation of
the surgical wound, which reduces the risk to the surgical
wound.11,23
According to our results, numerous studies have shown
the reduction of surgical wound complications through the
use of ciNPT.22-24 In addition, an international multi-
disciplinary consensus recommends the use of ciNPT in
patients classified as high risk for complications of surgical
wounds, based on the evidence published in different types
of surgical wounds.11,16
A second interesting finding of our study is the 3 days
better difference in the mean hospital stay in the ciNPT
group. In this regard, it is well studied that an SSI costs
approximately $20 000 US per patient.16
ciNPT costs are increased by $200 to 500 US per
patient compared with standard closure. However, ciNPT
could be cost-effective because of its reduction in SSIs
and hospital lengths of stay.16
Chopra et al described a savings of $1546 US per
patient after abdominal procedures.16,23
The main limitations of our study are its retrospective
nature and the presence of comorbidities in the patients.
However, to diminish bias, we selected all consecutive
patients who underwent laparotomy for gynaecologic
cancer and were divided into two periods based on the
application of ciNPT.
The preoperative and postoperative care is the same
in these cohorts and both groups do not present signifi-
cant differences between them.
Although it is a retrospective study that compares
two cohorts of patients operated at different times, the
comparable groups according to demographic data
allow us to compare the results with a low risk for
misinterpretation.
Despite the limitations described, our study highlights
the significant reductions in surgical wound complica-
tions and lengths of hospital stay in patients in whom
ciNPT has been used. Furthermore, it may decrease the
healthcare costs derived by those complications.
5 | CONCLUSION
In conclussion, the use of ciNPT to closure after laparot-
omy for gynaecological cancer is safe and effective for
decreasing SSIs and median hospital stay. The findings of
this study suggest clinical benefit with less rate of wound
complications. Consequently, the application of ciNPT
might be a cost-effective approach.
Therefore, we recommend to consider ciNPT after
laparotomy as part of clinical practice in patients at high
risk of wound complications, such as patients with
gynaecological malignancies.
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